FDA inspection
Antares Pharma, Inc.: FDA inspection ending Dec 4, 2018
FDA inspection 1073695 · Voluntary Action Indicated (VAI) · Minnetonka, MN
Key facts
| Inspection ID | 1073695 |
|---|---|
| Firm | Antares Pharma, Inc. |
| FEI number | 2182861 |
| Address | 3905 Annapolis Ln N Ste 105 |
| City | Minnetonka |
| State | MN |
| ZIP | 55343 |
| Country | United States |
| Fiscal year | 2019 |
| Inspection end date | Dec 4, 2018 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data